ResearcherVirginia Commonwealth UniversityNo recent work listed
Bridget A. Quinn
Matched on ORCID iD 0000-0003-3306-7749; OpenAlex author ID A5110966445. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2013: 1 paper · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper
Papers 7
- Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. Co-author DOI 10.18632/oncotarget.7931↗
- The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/bs.acr.2015.04.009↗
- Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach. First author DOI 10.1124/mol.114.094375↗
- Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. Co-author DOI 10.1158/0008-5472.can-14-3013↗
- Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. First author DOI 10.1158/0008-5472.can-14-0819↗
- Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus. Co-author DOI 10.2174/1566524013666131118110827↗
- Chemoprevention gene therapy (CGT): novel combinatorial approach for preventing and treating pancreatic cancer. Co-author DOI 10.2174/1566524011313070008↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paul B. Fisher · 7 shared papers, 2013–2016 · strength 0.32
- Paper Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. DOI 10.18632/oncotarget.7931↗
- Paper Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene t… DOI 10.1124/mol.114.094375↗
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Luni Emdad · 7 shared papers, 2013–2016 · strength 0.32
- Paper Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. DOI 10.18632/oncotarget.7931↗
- Paper Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene t… DOI 10.1124/mol.114.094375↗
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Siddik Sarkar · 4 shared papers, 2013–2015 · strength 0.17
- Paper Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene t… DOI 10.1124/mol.114.094375↗
- Paper Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. DOI 10.1158/0008-5472.can-14-3013↗
- Paper Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer ter… DOI 10.2174/1566524013666131118110827↗
- Maurizio Pellecchia · 3 shared papers, 2015–2016 · strength 0.15
- Paper Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. DOI 10.18632/oncotarget.7931↗
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Paper Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. DOI 10.1158/0008-5472.can-14-3013↗
- Praveen Bhoopathi · 3 shared papers, 2014–2015 · strength 0.14
- Paper The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocar… DOI 10.1016/bs.acr.2015.04.009↗
- Paper Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline. DOI 10.1158/0008-5472.can-14-3013↗
- Paper Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. DOI 10.1158/0008-5472.can-14-0819↗
- Paul Dent · 2 shared papers, 2014–2015 · strength 0.09
- Paper Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene t… DOI 10.1124/mol.114.094375↗
- Paper Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer ter… DOI 10.2174/1566524013666131118110827↗
- Susan Morvaridi · 1 shared paper, 2016 · strength 0.05
- Stephen Jacob Pandol · 1 shared paper, 2016 · strength 0.05
- Steven R. Grossman · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.